Teresa Freire Selected Research

apomucin

9/2005	Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
9/2003	Biochemical characterization of soluble Tn glycoproteins from malignant effusions of patients with carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Teresa Freire Research Topics

Disease

19	Neoplasms (Cancer) 04/2022 - 01/2003
8	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2003
7	Infections 07/2022 - 12/2015
4	Colonic Neoplasms (Colon Cancer) 12/2021 - 06/2010
3	Parasitic Diseases (Parasitic Disease) 12/2021 - 04/2016
3	Carcinoma (Carcinomatosis) 12/2003 - 01/2003
2	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2012
2	Echinococcosis (Hydatid Cysts) 12/2021 - 09/2004
2	Carcinogenesis 04/2016 - 06/2010
1	Reinfection 07/2022
1	Disease Progression 04/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Chagas Disease (American Trypanosomiasis) 01/2021
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 04/2020
1	Celiac Disease (Celiac Sprue) 04/2020
1	Trematode Infections (Fasciolopsiasis) 01/2020
1	Pseudohypoparathyroidism Type 2 12/2015
1	Adenocarcinoma 03/2011
1	Aberrant Crypt Foci 06/2010
1	Stomach Neoplasms (Stomach Cancer) 09/2003
1	Liver Neoplasms (Liver Cancer) 09/2003

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 04/2022 - 01/2003
9	MucinsIBA 05/2016 - 01/2003
7	Interleukin-10 (Interleukin 10)IBA 01/2022 - 12/2015
6	Polysaccharides (Glycans)IBA 04/2022 - 01/2003
6	CarbohydratesIBA 04/2022 - 09/2005
6	AntibodiesIBA 12/2021 - 01/2013
5	Tn antigenIBA 01/2022 - 01/2003
5	Peptides (Polypeptides)IBA 03/2016 - 09/2003
4	VaccinesIBA 11/2016 - 05/2006
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2010
3	CytokinesIBA 04/2020 - 05/2016
3	Polypeptide N-acetylgalactosaminyltransferaseIBA 09/2006 - 01/2003
3	Glycoproteins (Glycoprotein)IBA 05/2006 - 09/2003
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 05/2016
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2021 - 04/2016
2	Galactose (Galactopyranose)FDA LinkGeneric 10/2021 - 11/2010
2	LectinsIBA 10/2021 - 11/2010
2	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 04/2016 - 06/2010
2	Dimenhydrinate (DMH)FDA LinkGeneric 04/2016 - 06/2010
2	GlycoconjugatesIBA 12/2015 - 05/2006
2	GlycosyltransferasesIBA 09/2006 - 09/2005
2	AcetylgalactosamineIBA 09/2006 - 03/2006
2	N-AcetylgalactosaminyltransferasesIBA 09/2006 - 03/2006
2	Cell ExtractsIBA 05/2006 - 03/2006
2	apomucinIBA 09/2005 - 09/2003
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 07/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2022
1	TriclabendazoleIBA 07/2022
1	Interleukin-10 ReceptorsIBA 12/2021
1	Interleukin-5 (Interleukin 5)IBA 12/2021
1	Immunoglobulin G (IgG)IBA 12/2021
1	tryparedoxin peroxidaseIBA 01/2021
1	PeroxiredoxinsIBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	Immunoglobulin A (IgA)IBA 12/2019
1	EnzymesIBA 01/2017
1	Heme (Haem)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 05/2016
1	Interleukin-6 (Interleukin 6)IBA 05/2016
1	methylureaIBA 04/2016
1	Peptide Hydrolases (Proteases)FDA Link 03/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2015
1	Mannose (D-Mannose)IBA 12/2015
1	Cancer VaccinesIBA 09/2013
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 07/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2011
1	LigandsIBA 06/2010
1	Galectin 3 (LGALS3)IBA 06/2010
1	GlycopeptidesIBA 12/2006
1	Messenger RNA (mRNA)IBA 09/2006
1	Uridine Diphosphate (UDP)IBA 09/2006
1	Monoclonal AntibodiesIBA 05/2006
1	UridineIBA 03/2006
1	Recombinant ProteinsIBA 09/2005
1	TransferasesIBA 09/2004
1	sialosyl-Tn antigenIBA 12/2003
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2003
1	EpitopesIBA 09/2003

Therapy/Procedure

3	Immunotherapy 01/2022 - 05/2006